BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kerns SL, West CM, Andreassen CN, Barnett GC, Bentzen SM, Burnet NG, Dekker A, De Ruysscher D, Dunning A, Parliament M, Talbot C, Vega A, Rosenstein BS. Radiogenomics: the search for genetic predictors of radiotherapy response. Future Oncol 2014;10:2391-406. [PMID: 25525847 DOI: 10.2217/fon.14.173] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad I. Occupational radiation dose limits: Towards breaking the one-size-fits-all paradigm. Phys Med 2018;55:155-6. [PMID: 30340846 DOI: 10.1016/j.ejmp.2018.10.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Andreassen C, Eriksen J, Jensen K, Hansen C, Sørensen B, Lassen P, Alsner J, Schack L, Overgaard J, Grau C. IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncology 2018;86:91-9. [DOI: 10.1016/j.oraloncology.2018.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
3 Allison R, Dicker A. Minimizing morbidity in radiation oncology: a special issue from Future Oncology. Future Oncol 2014;10:2303-5. [PMID: 25525839 DOI: 10.2217/fon.14.195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
4 Xu L, Osei B, Osei E. A review of radiation genomics: integrating patient radiation response with genomics for personalised and targeted radiation therapy. J Radiother Pract 2019;18:198-209. [DOI: 10.1017/s1460396918000547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Song YZ, Duan MN, Zhang YY, Shi WY, Xia CC, Dong LH. ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis. Radiat Oncol 2015;10:247. [PMID: 26627042 DOI: 10.1186/s13014-015-0558-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Wu Y, Liu J, Del Rio AM, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES. Developing a clinical utility framework to evaluate prediction models in radiogenomics. Proc SPIE Int Soc Opt Eng 2015;9416:941617. [PMID: 27095854 DOI: 10.1117/12.2081954] [Reference Citation Analysis]
7 Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes. Sci Rep 2017;7:43381. [PMID: 28233873 DOI: 10.1038/srep43381] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
8 Andreassen CN. A simulated SNP experiment indicates a high risk of over-fitting and false positive results when a predictive multiple SNP model is established and tested within the same dataset. Radiotherapy and Oncology 2015;114:310-3. [DOI: 10.1016/j.radonc.2015.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
9 Ocolotobiche EE, Dauder RM, Güerci AM. Radiosensitivity of radiotherapy patients: The effect of individual DNA repair capacity. Mutat Res Genet Toxicol Environ Mutagen 2021;867:503371. [PMID: 34266627 DOI: 10.1016/j.mrgentox.2021.503371] [Reference Citation Analysis]
10 Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. Clin Oncol (R Coll Radiol) 2015;27:579-87. [PMID: 26166774 DOI: 10.1016/j.clon.2015.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
11 Ross JS, Gay LM. Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer. Pathology 2017;49:120-32. [DOI: 10.1016/j.pathol.2016.11.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 Agrawal JP, Erickson BJ, Kahn CE Jr. Imaging Informatics: 25 Years of Progress. Yearb Med Inform 2016;Suppl 1:S23-31. [PMID: 27362590 DOI: 10.15265/IYS-2016-s004] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
13 De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-johnson F. Radiotherapy toxicity. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0064-5] [Cited by in Crossref: 108] [Cited by in F6Publishing: 108] [Article Influence: 36.0] [Reference Citation Analysis]
14 Thrall JH. Moreton Lecture: Imaging in the Age of Precision Medicine. J Am Coll Radiol 2015;12:1106-11. [PMID: 26303360 DOI: 10.1016/j.jacr.2015.06.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
15 Wang TL, Ren YW, Wang HT, Yu H, Zhao YX. Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese. Med Sci Monit 2017;23:984-93. [PMID: 28231233 DOI: 10.12659/msm.899060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
16 Hall J, Jeggo PA, West C, Gomolka M, Quintens R, Badie C, Laurent O, Aerts A, Anastasov N, Azimzadeh O, Azizova T, Baatout S, Baselet B, Benotmane MA, Blanchardon E, Guéguen Y, Haghdoost S, Harms-Ringhdahl M, Hess J, Kreuzer M, Laurier D, Macaeva E, Manning G, Pernot E, Ravanat JL, Sabatier L, Tack K, Tapio S, Zitzelsberger H, Cardis E. Ionizing radiation biomarkers in epidemiological studies - An update. Mutat Res Rev Mutat Res 2017;771:59-84. [PMID: 28342453 DOI: 10.1016/j.mrrev.2017.01.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 16.0] [Reference Citation Analysis]
17 Senevirathna JDM, Asakawa S. Multi-Omics Approaches and Radiation on Lipid Metabolism in Toothed Whales. Life (Basel) 2021;11:364. [PMID: 33923876 DOI: 10.3390/life11040364] [Reference Citation Analysis]
18 Mbah C, De Ruyck K, De Schrijver S, De Sutter C, Schiettecatte K, Monten C, Paelinck L, De Neve W, Thierens H, West C, Amorim G, Thas O, Veldeman L. A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients. Acta Oncol 2018;57:604-12. [PMID: 29299946 DOI: 10.1080/0284186X.2017.1417633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
19 Aguado-Barrera ME, Martínez-Calvo L, Fernández-Tajes J, Calvo-Crespo P, Taboada-Valladares B, Lobato-Busto R, Gómez-Caamaño A, Vega A. Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients. Cancers (Basel) 2021;13:1447. [PMID: 33810047 DOI: 10.3390/cancers13061447] [Reference Citation Analysis]
20 Azria D, Lapierre A, Gourgou S, De Ruysscher D, Colinge J, Lambin P, Brengues M, Ward T, Bentzen SM, Thierens H, Rancati T, Talbot CJ, Vega A, Kerns SL, Andreassen CN, Chang-Claude J, West CML, Gill CM, Rosenstein BS. Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. Front Oncol 2017;7:83. [PMID: 28497027 DOI: 10.3389/fonc.2017.00083] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
21 Benafif S, Eeles R. Genetic predisposition to prostate cancer. Br Med Bull 2016;120:75-89. [PMID: 27941040 DOI: 10.1093/bmb/ldw039] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
22 Brengues M, Lapierre A, Bourgier C, Pèlegrin A, Özsahin M, Azria D. T lymphocytes to predict radiation-induced late effects in normal tissues. Expert Review of Molecular Diagnostics 2016;17:119-27. [DOI: 10.1080/14737159.2017.1271715] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
23 De Ruysscher D, Defraene G, Ramaekers BLT, Lambin P, Briers E, Stobart H, Ward T, Bentzen SM, Van Staa T, Azria D, Rosenstein B, Kerns S, West C. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement. Radiother Oncol 2016;121:440-6. [PMID: 27979370 DOI: 10.1016/j.radonc.2016.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
24 Collado K, Kerns SL, Diefenbach MA, Peterson-Roth E, Koski R, Ostrer H, Stock RG, Mattessich M, Kaplan P, Rosenstein BS. Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. Adv Radiat Oncol 2020;5:897-904. [PMID: 33083651 DOI: 10.1016/j.adro.2020.03.019] [Reference Citation Analysis]
25 Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES. Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation. J Med Imaging (Bellingham) 2015;2:041005. [PMID: 26835489 DOI: 10.1117/1.JMI.2.4.041005] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Talbot CJ, Veldwijk MR, Azria D, Batini C, Bierbaum M, Brengues M, Chang-Claude J, Johnson K, Keller A, Smith S, Sperk E, Symonds RP, Wenz F, West CML, Herskind C, Bourgier C. Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity. Clin Transl Radiat Oncol 2019;18:1-8. [PMID: 31341970 DOI: 10.1016/j.ctro.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 Rosenstein BS, Capala J, Efstathiou JA, Hammerbacher J, Kerns SL, Kong FS, Ostrer H, Prior FW, Vikram B, Wong J, Xiao Y. How Will Big Data Improve Clinical and Basic Research in Radiation Therapy? Int J Radiat Oncol Biol Phys 2016;95:895-904. [PMID: 26797542 DOI: 10.1016/j.ijrobp.2015.11.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
28 Hoeben BAW, Wong JYC, Fog LS, Losert C, Filippi AR, Bentzen SM, Balduzzi A, Specht L. Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions. Front Pediatr 2021;9:774348. [PMID: 34926349 DOI: 10.3389/fped.2021.774348] [Reference Citation Analysis]
29 Borchiellini D, Etienne-grimaldi M, Bensadoun R, Benezery K, Dassonville O, Poissonnet G, Llorca L, Ebran N, Formento P, Château Y, Thariat J, Milano G. Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer. Oral Oncology 2017;67:70-6. [DOI: 10.1016/j.oraloncology.2017.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
30 Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, Sutton EJ, Morris EA. Background, current role, and potential applications of radiogenomics.J Magn Reson Imaging. 2018;47:604-620. [PMID: 29095543 DOI: 10.1002/jmri.25870] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 14.2] [Reference Citation Analysis]
31 Scaife JE, Barnett GC, Noble DJ, Jena R, Thomas SJ, West CM, Burnet NG. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015;88:20150172. [PMID: 26084351 DOI: 10.1259/bjr.20150172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
32 Rosenstein BS. Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity. Semin Radiat Oncol 2017;27:300-9. [PMID: 28865512 DOI: 10.1016/j.semradonc.2017.04.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
33 Niedzielski JS, Yang J, Stingo F, Liao Z, Gomez D, Mohan R, Martel M, Briere T, Court L. A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials. Sci Rep 2017;7:6034. [PMID: 28729729 DOI: 10.1038/s41598-017-05003-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
34 Ahmed M, Dorling L, Kerns S, Fachal L, Elliott R, Partliament M, Rosenstein BS, Vega A, Gómez-Caamaño A, Barnett G, Dearnaley DP, Hall E, Sydes M, Burnet N, Pharoah PD, Eeles R, West CM. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. Br J Cancer 2016;114:1165-74. [PMID: 27070714 DOI: 10.1038/bjc.2016.94] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
35 Nieder C. Second re-irradiation: A delicate balance between safety and efficacy. Physica Medica 2019;58:155-8. [DOI: 10.1016/j.ejmp.2019.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
36 Jafari-Khouzani K, Loebel F, Bogner W, Rapalino O, Gonzalez GR, Gerstner E, Chi AS, Batchelor TT, Rosen BR, Unkelbach J, Shih HA, Cahill DP, Andronesi OC. Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. Neuro Oncol 2016;18:1569-78. [PMID: 27382115 DOI: 10.1093/neuonc/now100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
37 Andreassen CN, Schack LMH, Laursen LV, Alsner J. Radiogenomics – current status, challenges and future directions. Cancer Letters 2016;382:127-36. [DOI: 10.1016/j.canlet.2016.01.035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]
38 Hill RP. The changing paradigm of tumour response to irradiation. Br J Radiol 2017;90:20160474. [PMID: 27416998 DOI: 10.1259/bjr.20160474] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
39 Gong L, Luo M, Sun R, Qiu L, Chen C, Luo Z. Significant Association Between XRCC1 Expression and Its rs25487 Polymorphism and Radiotherapy-Related Cancer Prognosis. Front Oncol 2021;11:654784. [PMID: 34094945 DOI: 10.3389/fonc.2021.654784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Ma W, Liu R, Huang L, Zou C, Huang J, Wang J, Chen S, Meng X, Yang J, Li H, Yang G, Guo C. Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma. Clin Exp Pharmacol Physiol 2017;44:539-48. [DOI: 10.1111/1440-1681.12738] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
41 El Naqa I, Kerns SL, Coates J, Luo Y, Speers C, West CML, Rosenstein BS, Ten Haken RK. Radiogenomics and radiotherapy response modeling. Phys Med Biol 2017;62:R179-206. [PMID: 28657906 DOI: 10.1088/1361-6560/aa7c55] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
42 Thon N, Tonn JC, Kreth FW. The surgical perspective in precision treatment of diffuse gliomas. Onco Targets Ther 2019;12:1497-508. [PMID: 30863116 DOI: 10.2147/OTT.S174316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J; International Radiogenomics Consortium (RgC). Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol 2016;121:431-9. [PMID: 27443449 DOI: 10.1016/j.radonc.2016.06.017] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 10.7] [Reference Citation Analysis]
44 McKay MJ, Maneerat J, McKay TM, McKay JN, Masoud-Rahbari R. In vitro prediction of breast cancer therapy toxicity. Ann Transl Med 2017;5:94. [PMID: 28361059 DOI: 10.21037/atm.2017.02.27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
45 De Ruysscher D, Jin J, Lautenschlaeger T, She JX, Liao Z, Kong FS. Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy. Transl Lung Cancer Res 2017;6:661-9. [PMID: 29218269 DOI: 10.21037/tlcr.2017.09.12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
46 De Ruysscher D, Granton PV, Lieuwes NG, van Hoof S, Wollin L, Weynand B, Dingemans AM, Verhaegen F, Dubois L. Nintedanib reduces radiation-induced microscopic lung fibrosis but this cannot be monitored by CT imaging: A preclinical study with a high precision image-guided irradiator. Radiother Oncol 2017;124:482-7. [PMID: 28774597 DOI: 10.1016/j.radonc.2017.07.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
47 Guo CX, Wang J, Huang LH, Li JG, Chen X. Impact of single-nucleotide polymorphisms on radiation pneumonitis in cancer patients. Mol Clin Oncol 2016;4:3-10. [PMID: 26870349 DOI: 10.3892/mco.2015.666] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
48 Zhang SQ, Pan SM, Liang SX, Han YS, Chen HB, Li JC. Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review). Int J Oncol 2021;58:9. [PMID: 33649830 DOI: 10.3892/ijo.2021.5188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
49 Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS. The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. Semin Radiat Oncol 2015;25:281-91. [PMID: 26384276 DOI: 10.1016/j.semradonc.2015.05.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
50 Massi MC, Gasperoni F, Ieva F, Paganoni AM, Zunino P, Manzoni A, Franco NR, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Symonds PR, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Avuzzi B, Giandini T, Valdagni R, Cicchetti A, Azria D, Jacquet MF, Rosenstein BS, Stock RG, Collado K, Vega A, Aguado-Barrera ME, Calvo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T. A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. Front Oncol 2020;10:541281. [PMID: 33178576 DOI: 10.3389/fonc.2020.541281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]